Skip to content
Review Open access

Epstein–Barr Virus–host epigenetic interplay: mechanisms of regulation and therapeutic potential

Jul 2026 · Clinical Epigenetics · Vol 18 · 1 citation · 117 references
Medicine

Abstract

The Epstein-Barr virus (EBV) has evolved complex mechanisms to manipulate the host immune system and epigenetic machinery, enabling it to establish lifelong latent infection within host cells. Emerging evidence strongly indicates that the EBV acts as a main epigenetic manipulator by silencing host regulatory genes, altering host chromatin landscapes and exploiting B-cell biology. Key mechanisms include viral-mediated recruitment of host DNA methyltransferases and histone-modifying enzymes; modulation of host non-coding RNAs and chromatin architectural factors; and targeted disruption of interferon signaling through RNA methylation and restructuring of host chromatin. These integrated processes allow EBV to maintain a lifelong infection in humans, evade both innate and adaptive immunity, and respond to reactivation signals. Understanding the virus-host epigenetic interplay offers new opportunities for therapeutic interventions targeting epigenetic regulators in EBV-associated diseases.

Read PDF

Similar papers

Review Sep 2026

Epigenetic Regulation of Host Immunity During Parasitic Infections: Mechanisms, Immune Evasion, and Therapeutic Opportunities.

Epigenetic regulation represents a central mechanism governing host-parasite interactions and integrating advanced approaches, including single-cell epigenomics and spatial transcriptomics, may clarify cell-specific mechanisms and identify novel biomarkers and therapeutic targets.

H. Alzaylaee, W. Elkholy, Marwa A. Elkholy et al. · 0 citations
Review Open access Sep 2026

Epigenetic Regulation of Immune Responses in Chickens: Mechanisms, Host–Pathogen Interactions, and Emerging Genomic Technologies

Epigenetic regulation has emerged as a fundamental mechanism governing immune function in poultry by integrating genetic, environmental, nutritional, and microbial signals without altering the DNA sequence. Recent advances in epigenomics have revealed that DNA methylation, histone modifications, chromatin remodeling, a...

M. Naeem · 0 citations
Review Open access Sep 2026

Epitranscriptomic Regulation in Oncogenic Viruses: Emerging Roles of RNA Modifications in Viral Persistence and Tumourigenesis.

Oncogenic viral pathogens, such as human papillomavirus (HPV), Epstein-Barr virus (EBV), hepatitis B and C viruses (HBV, HCV), and Kaposi's sarcoma-associated herpesvirus (KSHV), are involved in a significant proportion of human cancers worldwide. While genetic and epigenetic mechanisms underlying viral oncogenesis hav...

Zi-Nan Yang, Yang Bai, Li-Hui Jia et al. · 0 citations
Review Open access Sep 2026

Epigenetic regulation of HIV-1 transcription: insights into latency mechanisms and therapeutic strategies

HIV-1 is one of the most serious pathogens currently threatening human health worldwide. Although antiretroviral therapy (ART) effectively suppresses HIV-1 replication, it fails to eliminate the latent reservoir of transcriptionally silent proviruses that persist in long-lived cells, making HIV-1 latency the major obst...

Shu-Han Yang, Jin-Song Yuan, Xiao-Dong Sun et al. · 0 citations
Review Open access Sep 2026

Modulation of DNA Damage by Epstein–Barr Virus (EBV)

Epstein–Barr Virus (EBV) is an oncogenic gammaherpesvirus present in >95% of the adult population. EBV is responsible for nearly 2% of the global cancer burden and is a contributing factor in the development and progression of both epithelial and lymphoid malignancies. Throughout its lifecycle, EBV manipulates the DNA...

Emily DiMaulo-Milk, B. Damania · 0 citations
Review Open access Sep 2026

HMGB1 Post-Translational Modifications in Epstein–Barr Virus-Associated Nasopharyngeal Carcinoma: Current Evidence, Emerging Mechanistic Concepts, and Unresolved Questions

Nasopharyngeal carcinoma (NPC) is a geographically distinct malignancy closely associated with Epstein–Barr virus (EBV) infection and characterized by extensive epigenetic reprogramming within a highly immunosuppressive tumor microenvironment (TME). High-mobility group box 1 (HMGB1), a multifunctional chromatin-binding...

Cho-Yiu Lau, K. S. Khan, D. Kwong et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.